859
Participants
Start Date
November 30, 1997
Primary Completion Date
June 30, 2000
piperacillin sodium
piperacillin-tazobactam
tazobactam sodium
vancomycin
Institut Jules Bordet, Brussels (Bruxelles)
Hopital Universitaire Erasme, Brussels
Cliniques Universitaires Saint-Luc, Brussels (Bruxelles)
Algemeen Ziekenhuis Middelheim, Antwerp
Hellenic Institute for Cancer-Saint Savas Hospital, Athens
Athens University-Laikon General Hospital, Athens
Metaxa's Memorial Cancer Hospital, Piraeus
Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore
CHR de Besancon - Hopital Saint-Jacques, Besançon
Chaim Sheba Medical Center, Ramat Gan
Wolfson Medical Center, Holon
Marmara University Hospital, Istanbul
Hadassah University Hospital, Jerusalem
Boston Medical Center, Boston
Kingston General Hospital, Kingston
Ottawa Regional Cancer Center - General Division, Ottawa
Masaryk University Hospital, Brno
Turku University Central Hospital, Turku
Klinikum der Universitaet Ulm, Ulm
University of Patras Medical School, Rio Patras
National Cancer Institute - Bratislava, Bratislava
St. Elizabeth Cancer Institute Hospital, Bratislava
Ospedale San Giovanni, Bellinzona
Centre Hospitalier Universitaire Vaudois, Lausanne
Universitaetsspital, Zurich
Ibn-i Sina Hospital, Ankara Univeristy, Ankara
Section of Infectious Diseases, Ankara
Royal Marsden Hospital, Sutton
European Organisation for Research and Treatment of Cancer - EORTC
NETWORK